Igene Biotechnology, Inc. (IGNE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Igene Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 2001 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '10 Sep 30, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 2001 - 2005 |
| 0 | 3.96 | 7.64 | 2.29 | - | - | Upgrade | |
Revenue Growth (YoY) | -99.91% | -48.23% | 234.30% | - | - | - | Upgrade |
Cost of Revenue | -0.04 | 2.94 | 6.4 | 1.68 | - | - | Upgrade |
Gross Profit | 0.04 | 1.02 | 1.25 | 0.61 | - | - | Upgrade |
Selling, General & Admin | 0.94 | 1.23 | 1.78 | 1.13 | 1.12 | 1.09 | Upgrade |
Research & Development | 2.04 | 1.85 | 1.66 | 0.98 | 0.85 | 0.82 | Upgrade |
Other Operating Expenses | -2.35 | -2.09 | - | -1.58 | -1.66 | -1.83 | Upgrade |
Operating Expenses | 0.64 | 0.99 | 3.44 | 0.54 | 0.31 | 0.08 | Upgrade |
Operating Income | -0.6 | 0.02 | -2.19 | 0.07 | -0.31 | -0.08 | Upgrade |
Interest Expense | -0.06 | -0.1 | -2.03 | -2.21 | -2.11 | -1.48 | Upgrade |
Interest & Investment Income | - | - | - | 0.05 | 0.08 | - | Upgrade |
Earnings From Equity Investments | -1.73 | -1.09 | - | 0.17 | -0.11 | -0.37 | Upgrade |
Other Non Operating Income (Expenses) | 0.02 | 0 | 0.23 | 0.02 | 0.01 | - | Upgrade |
EBT Excluding Unusual Items | -2.37 | -1.17 | -3.99 | -1.9 | -2.43 | -1.93 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.01 | - | -0.11 | Upgrade |
Other Unusual Items | - | 1.03 | - | - | - | - | Upgrade |
Pretax Income | -2.37 | -0.14 | -3.99 | -1.9 | -2.43 | -2.04 | Upgrade |
Earnings From Continuing Operations | -2.37 | -0.14 | -3.99 | -1.9 | -2.43 | -2.04 | Upgrade |
Net Income | -2.37 | -0.14 | -3.99 | -1.9 | -2.43 | -2.04 | Upgrade |
Net Income to Common | -2.37 | -0.14 | -3.99 | -1.9 | -2.43 | -2.04 | Upgrade |
Shares Outstanding (Basic) | 1,563 | 1,538 | 187 | 110 | 108 | 103 | Upgrade |
Shares Outstanding (Diluted) | 1,563 | 1,538 | 187 | 110 | 108 | 103 | Upgrade |
Shares Change (YoY) | 24.87% | 722.18% | 70.53% | 1.19% | 4.84% | 7.01% | Upgrade |
EPS (Basic) | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade |
EPS (Diluted) | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade |
Free Cash Flow | -1.67 | -0.27 | 0.48 | 1.04 | 0 | 0.29 | Upgrade |
Free Cash Flow Per Share | -0.00 | - | 0.00 | 0.01 | - | 0.00 | Upgrade |
Gross Margin | 850.27% | 25.66% | 16.34% | 26.46% | - | - | Upgrade |
Operating Margin | -12422.32% | 0.62% | -28.63% | 2.94% | - | - | Upgrade |
Profit Margin | -49414.72% | -3.56% | -52.21% | -83.05% | - | - | Upgrade |
Free Cash Flow Margin | -34666.49% | -6.79% | 6.27% | 45.28% | - | - | Upgrade |
EBITDA | -0.43 | 0.21 | -1.82 | 0.08 | -0.29 | -0.06 | Upgrade |
EBITDA Margin | - | 5.21% | -23.76% | 3.48% | - | - | Upgrade |
D&A For EBITDA | 0.17 | 0.18 | 0.37 | 0.01 | 0.02 | 0.02 | Upgrade |
EBIT | -0.6 | 0.02 | -2.19 | 0.07 | -0.31 | -0.08 | Upgrade |
EBIT Margin | - | 0.62% | -28.63% | 2.94% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.